Sep 19 2026 04:36 AM EST
Hormel Foods' Q3 Earnings Reveal Cost Pressures as Shares Lag Benchmark
Hormel Foods Corporation (NASDAQ: HRL) reported Q3 fiscal 2026 results on Aug 27, 2026 that showed a 2.4% YoY decline in net sales to $2.961 billion and a 67.6% drop in GAAP net earnings to $59.6 million. The earnings miss, combined with a tightened FY 2026 outlook, has left the stock down 12% over the past year, underperforming its benchmark by more than ten percentage points.
GAAP diluted EPS fell to $0.11 versus $0.33 a year earlier, while non‑GAAP adjusted diluted EPS rose modestly to $0.37 from $0.35, reflecting an adjusted operating income of $266.2 million (+4.7% YoY) after excluding Transform‑and‑Modernize, divestiture, litigation, impairment and restructuring charges.
Margin Compression Drives the Underperformance
Operating income fell to $110.9 million, a 56.4% decline YoY, and operating margin slipped to 7.2% for the trailing twelve months, down from 8.5% in 2024 and 8.3% in 2025. Gross profit margin also fell to 15.7%. The compression stems from persistent input‑cost inflation—pork bellies up 30% YoY, pork cutout up 10%, and beef at near‑all‑time highs—adding roughly 400 bps of raw‑material cost pressure in Q3 alone.
Logistics and Freight Add to Expense Burden
Elevated transportation costs, driven by winter‑related disruptions and broader geopolitical factors, have kept freight expenses high throughout FY 2026. The company noted that logistics headwinds, combined with higher freight rates, have further pressured margins despite a 54% YoY increase in operating cash flow to $240.6 million.
Segment Performance Highlights Divergence
Retail organic net sales declined 3.3% (reported –4.3% YoY) and segment profit fell 3.7%, reflecting a choppy consumer environment. By contrast, Foodservice posted its 12th consecutive quarter of organic growth, with sales up 1.8% (reported +1.6%) and segment profit rising 2.7%. International sales fell 4.4% (reported –4.7%) and swung to a loss of $29.2 million versus a $18.9 million profit a year earlier, driven by a one‑time legal‑entity transition affecting SPAM export sales and a non‑cash impairment of an Indonesian minority investment of $48.2 million.
Guidance Tightened as Management Reassesses Outlook
On Aug 27, 2026 Hormel narrowed its FY 2026 sales outlook to $12.1‑$12.2 billion (previously $12.2‑$12.5 billion) and lowered organic growth guidance to 1%‑2% (previously 1%‑4%). Diluted EPS guidance was cut to $1.06‑$1.12 from $1.28‑$1.37, while adjusted diluted EPS guidance was modestly raised to $1.45‑$1.51.
Management cited the “strong year‑to‑date performance” and confidence in delivering adjusted earnings growth, but also acknowledged that pricing actions initiated in late 2025 are expected to contribute only in Q4 2026 and beyond, leaving near‑term margin expansion limited.
Strategic Portfolio Moves and One‑Time Charges
The company completed the divestiture of its Brazil Ceratti operations, generating a cash outflow of $97.1 million and removing a low‑margin, volatile business. Additional one‑time items in Q3 included a $37.5 million antitrust litigation settlement and a $48.2 million impairment of the Indonesian investment. These items reduced GAAP profitability but are excluded from the adjusted earnings metric.
Macro Context and Competitive Landscape
U.S. CPI remained elevated at +0.4% in August 2026 and +3.4% YoY, keeping input‑cost pressure high across the food sector. Freight constraints linked to weather and geopolitical factors have broadly lifted logistics expenses for peers, limiting the ability of food‑product manufacturers to absorb cost increases without eroding margins.
Competitors that have faster price‑adjustment cycles or more diversified international exposure have shown relatively stronger share‑price performance, underscoring the relative impact of Hormel’s cost structure and the timing of its pricing actions.
Risks and Outlook
Key risks include continued input‑cost inflation, especially if pork and beef prices remain near historic highs, and the possibility that pricing actions may not fully offset these costs before inventory adjustments absorb the benefit. The International segment’s one‑time legal‑entity transition and impairment charge could recur if similar restructuring occurs in other markets.
The dividend remains a priority, supported by a strong balance sheet, but leverage at a net‑debt‑to‑EBITDA ratio of 2.0 suggests limited flexibility for additional share‑repurchase activity. Investors will be watching the Q4 2026 results for evidence that pricing actions and the Transform‑and‑Modernize initiative begin to translate into margin recovery.